Some but not all of HLA-II alleles are associated with cervical cancer in Chinese women

Cancer Genetics and Cytogenetics

Volumn 187, Issue 2, 2008, Pages 95-100

  Liang, Jinxiao ^a   Xu, Anlong ^a   Xie, Yufen ^b   Awonuga, Awoniyi O ^b   Lin, Zhongqiu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; HLA ANTIGEN CLASS 2; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; GENE FREQUENCY; GENES, MHC CLASS II; HAPLOTYPES; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 56249105848     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.07.011     Document Type: Article

References (35)

1. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80 (1999) 827-841
2. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94 (2001) 153-156
3. Beskow A.H., and Gyllensten U.B. Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri. Int J Cancer 101 (2002) 526-531
4. Chan P.K., Yu M.M., Cheung T.H., To K.F., Lo K.W., Cheung J.L., and Tong J.H. Detection and quantitation of human papillomavirus DNA in primary tumour and lymph nodes of patients with early stage cervical carcinoma. J Clin Virol 33 (2005) 201-205
5. Wu Y., Chen Y., Li L., Yu G., Zhang Y., and He Y. Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 35 (2006) 264-269
6. Zhao F.H., Forman M.R., Belinson J., Shen Y.H., Graubard B.I., Patel A.C., Rong S.D., Pretorius R.G., and Qiao Y.L. Risk factors for HPV infection and cervical cancer among unscreened women in a high-risk rural area of China. Int J Cancer 118 (2006) 442-448
7. Arias-Pulido H., Joste N., and Wheeler C.M. Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinomas carrying the DRB1*1501-DQB1*0602 haplotype. Genes Chromosomes Cancer 40 (2004) 277-284
8. Madeleine M.M., Brumback B., Cushing-Haugen K.L., Schwartz S.M., Daling J.R., Smith A.G., Nelson J.L., Porter P., Shera K.A., McDougall J.K., and Galloway D.A. Human leukocyte antigen class II and cervical cancer risk: a population-based study. J Infect Dis 186 (2002) 1565-1574
9. Apple R.J., Erlich H.A., Klitz W., Manos M.M., Becker T.M., and Wheeler C.M. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 6 (1994) 157-162
10. Beskow A.H., Josefsson A.M., and Gyllensten U.B. HLA class II alleles associated with infection by HPV16 in cervical cancer in situ. Int J Cancer 93 (2001) 817-822
11. Cuzick J., Terry G., Ho L., Monaghan J., Lopes A., Clarkson P., and Duncan I. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer 82 (2000) 1348-1352
12. Lin P., Koutsky L.A., Critchlow C.W., Apple R.J., Hawes S.E., Hughes J.P., Toure P., Dembele A., and Kiviat N.B. HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women. Cancer Epidemiol Biomarkers Prev 10 (2001) 1037-1045
13. Sastre-Garau X., Loste M.N., Vincent-Salomon A., Favre M., Mouret E., de la Rochefordiere A., Durand J.C., Tartour E., Lepage V., and Charron D. Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix. Int J Cancer 69 (1996) 159-164
14. Hildesheim A., Schiffman M., Scott D.R., Marti D., Kissner T., Sherman M.E., Glass A.G., Manos M.M., Lorincz A.T., Kurman R.J., Buckland J., Rush B.B., and Carrington M. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States. Cancer Epidemiol Biomarkers Prev 7 (1998) 1035-1041
15. Davidson E.J., Davidson J.A., Sterling J.C., Baldwin P.J., Kitchener H.C., and Stern P.L. Association between human leukocyte antigen polymorphism and human papillomavirus 16-positive vulval intraepithelial neoplasia in British women. Cancer Res 63 (2003) 400-403
16. Jia Z.J., Pan D.J., Fu Y.G., Chen W.M., Liu Z.H., Lin J.H., Zhu Y.F., Chen R.X., Fu Z.Y., Zhou D.M., and Xu A.L. [HLA-DRB1 gene polymorphism of Naxi ethnic group of Yunnan Province, China and its ethnological evolution analysis]. Yi Chuan Xue Bao 28 (2001) 1107-1115
17. Kotsch K., Wehling J., and Blasczyk R. Sequencing of HLA class II genes based on the conserved diversity of the non-coding regions: sequencing based typing of HLA-DRB genes. Tissue Antigens 53 (1999) 486-497
18. Versluis L.F., Rozemuller E., Tonks S., Marsh S.G., Bouwens A.G., Bodmer J.G., and Tilanus M.G. High-resolution HLA-DPB typing based upon computerized analysis of data obtained by fluorescent sequencing of the amplified polymorphic exon 2. Hum Immunol 38 (1993) 277-283
19. Wu Y., Chen Y., Li L., Cao Y., Liu Z., Liu B., Du Z., Zhang Y., Chen S., Lin Z., and Xu A. Polymorphic amino acids at codons 9 and 37 of HLA-DQB1 alleles may confer susceptibility to cervical cancer among Chinese women. Int J Cancer 118 (2006) 3006-3011
20. Fu Y., Liu Z., Lin J., Chen W., Jia Z., Pan D., and Xu A. Extensive polymorphism and different evolutionary patterns of intron 2 were identified in the HLA-DQB1 gene. Immunogenetics 54 (2003) 761-766
21. Xiang Y., Gao Y., and Wang T. [Application and comparison of meta and pooled analyses in the study of cancer epidemiology]. Zhonghua Zhong Liu Za Zhi 21 (1999) 354-358
22. Chan D.P., Cheung T.H., Tam A.O., Cheung J.L., Yim S.F., Lo K.W., Siu N.S., Zhou D.X., and Chan P.K. Risk association between human leukocyte antigen-A allele and high-risk human papillomavirus infection for cervical neoplasia in Chinese women. J Infect Dis 192 (2005) 1749-1756
23. Chan P.K., Cheung J.L., Cheung T.H., Lin C.K., Tam A.O., Chan D.P., Zhou D.X., Lo K.W., Yim S.F., and Siu S.S. HLA-B alleles, high-risk HPV infection and risk for cervical neoplasia in southern Chinese women. Int J Cancer 118 (2006) 1430-1435
24. Wu Y., Liu B., Lin W., Xu Y., Li L., Zhang Y., Chen S., Lin Z., and Xu A. Human leukocyte antigen class II alleles and risk of cervical cancer in China. Hum Immunol 68 (2007) 192-200
25. Neuman R.J., Huettner P.C., Li L., Mardis E.R., Duffy B.F., Wilson R.K., and Rader J.S. Association between DQB1 and cervical cancer in patients with human papillomavirus and family controls. Obstet Gynecol 95 (2000) 134-140
26. Mehal W.Z., Lo Y.M., Herrington C.S., Evans M.F., Papadopoulos M.C., Odunis K., Ganesan T.S., McGee J.O., Bell J.I., and Fleming K.A. Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesis. J Clin Pathol 47 (1994) 1077-1081
27. Wank R., and Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 352 (1991) 723-725
28. Duggan-Keen M.F., Keating P.J., Stevens F.R., Sinnott P., Snijders P.J., Walboomers J.M., Davidson S., Hunter R.D., Dyer P.A., and Stern P.L. Immunogenetic factors in HPV-associated cervical cancer: influence on disease progression. Eur J Immunogenet 23 (1996) 275-284
29. Allen M., Kalantari M., Ylitalo N., Pettersson B., Hagmar B., Scheibenpflug L., Johansson B., Petterson U., and Gyllensten U. HLA DQ-DR haplotype and susceptibility to cervical carcinoma: indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18. Tissue Antigens 48 (1996) 32-37
30. Maciag P.C., Schlecht N.F., Souza P.S., Franco E.L., Villa L.L., and Petzl-Erler M.L. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiol Biomarkers Prev 9 (2000) 1183-1191
31. Sanjeevi C.B., Hjelmstrom P., Hallmans G., Wiklund F., Lenner P., Angstrom T., Dillner J., and Lernmark A. Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women. Int J Cancer 68 (1996) 409-414
32. Dehaghani A.S., Amirzargar A., Farjadian S., and Ghaderi A. HLA-DQBl alleles and susceptibility to cervical squamous cell carcinoma in Southern Iranian patients. Pathol Oncol Res 8 (2002) 58-61
33. Silva B., Vargas-Alarcon G., Zuniga-Ramos J., Rodriguez-Reyna T.S., Hernandez-Martinez B., Osnaya N., Kofman S., Torres-Lobaton A., and Granados J. Genetic features of Mexican women predisposing to cancer of the uterine cervix. Hum Pathol 30 (1999) 626-628
34. Wang S.S., Wheeler C.M., Hildesheim A., Schiffman M., Herrero R., Bratti M.C., Sherman M.E., Alfaro M., Hutchinson M.L., Morales J., Lorincz A., Burk R.D., Carrington M., Erlich H.A., and Apple R.J. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. J Infect Dis 184 (2001) 1310-1314
35. Montoya L., Saiz I., Rey G., Vela F., and Clerici-Larradet N. Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population. Eur J Immunogenet 25 (1998) 329-337